JP2008500345A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500345A5 JP2008500345A5 JP2007515217A JP2007515217A JP2008500345A5 JP 2008500345 A5 JP2008500345 A5 JP 2008500345A5 JP 2007515217 A JP2007515217 A JP 2007515217A JP 2007515217 A JP2007515217 A JP 2007515217A JP 2008500345 A5 JP2008500345 A5 JP 2008500345A5
- Authority
- JP
- Japan
- Prior art keywords
- dry particle
- interferon
- surfactant
- particle preparation
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002245 particle Substances 0.000 claims description 24
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 108010045648 interferon omega 1 Proteins 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims 15
- 108010050904 Interferons Proteins 0.000 claims 12
- 102000014150 Interferons Human genes 0.000 claims 12
- 229940079322 interferon Drugs 0.000 claims 12
- 239000000872 buffer Substances 0.000 claims 6
- 235000014633 carbohydrates Nutrition 0.000 claims 5
- 239000003381 stabilizer Substances 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000003963 antioxidant agent Substances 0.000 claims 4
- 150000001720 carbohydrates Chemical class 0.000 claims 4
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical group [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 claims 1
- 235000010983 sucrose acetate isobutyrate Nutrition 0.000 claims 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57466204P | 2004-05-25 | 2004-05-25 | |
| US65022605P | 2005-02-03 | 2005-02-03 | |
| PCT/US2005/017914 WO2005115333A2 (en) | 2004-05-25 | 2005-05-23 | A biomolecule-containing formulation of increased stability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008500345A JP2008500345A (ja) | 2008-01-10 |
| JP2008500345A5 true JP2008500345A5 (enExample) | 2008-07-17 |
Family
ID=35451371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007515217A Withdrawn JP2008500345A (ja) | 2004-05-25 | 2005-05-23 | 増加された安定度をもつ生体分子含有調製物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050266087A1 (enExample) |
| EP (1) | EP1755650B8 (enExample) |
| JP (1) | JP2008500345A (enExample) |
| KR (1) | KR20070046791A (enExample) |
| AR (1) | AR049118A1 (enExample) |
| AT (1) | ATE400291T1 (enExample) |
| AU (1) | AU2005247439B2 (enExample) |
| BR (1) | BRPI0511593A (enExample) |
| CA (1) | CA2568714A1 (enExample) |
| DE (1) | DE602005008053D1 (enExample) |
| ES (1) | ES2309768T3 (enExample) |
| IL (1) | IL179279A (enExample) |
| MX (1) | MXPA06013755A (enExample) |
| NZ (1) | NZ551258A (enExample) |
| PE (1) | PE20060456A1 (enExample) |
| TW (1) | TW200611712A (enExample) |
| WO (1) | WO2005115333A2 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
| US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| EP1536767B1 (en) * | 2002-06-17 | 2007-08-08 | Alza Corporation | Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| SI1575569T1 (sl) | 2002-12-13 | 2010-12-31 | Durect Corp | Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| EP1613389B8 (en) * | 2003-03-31 | 2008-05-07 | Intarcia Therapeutics, Inc. | Osmotic pump with means for dissipating internal pressure |
| CA2520766A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| PL380763A1 (pl) * | 2003-10-31 | 2007-03-05 | Alza Corporation | Pompa osmotyczna z samoczynnie mocowanym korkiem membranowym szybkiego uruchamiania |
| KR20060121890A (ko) * | 2003-11-06 | 2006-11-29 | 알자 코포레이션 | 이식형 삼투 펌프와 함께 사용하기 위한 모듈식 흡수율감소기 |
| US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| SI2767292T1 (sl) | 2004-09-17 | 2017-01-31 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
| EP1877077A2 (en) * | 2005-02-03 | 2008-01-16 | Intarcia Therapeutics, Inc. | An implantable interferon-containing device |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US7959938B2 (en) * | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
| MX2009001114A (es) | 2006-08-09 | 2009-02-10 | Intarcia Therapeutics Inc | Sistemas de suministro osmotico y ensambles de piston. |
| EP2117521B1 (en) | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| CN104000779A (zh) | 2007-04-23 | 2014-08-27 | 精达制药公司 | 促胰岛素释放肽的混悬制剂及其应用 |
| US20080268270A1 (en) * | 2007-04-30 | 2008-10-30 | Wenjie Chen | High impact polymer interlayers |
| EP2067471B1 (en) | 2007-12-06 | 2018-02-14 | Durect Corporation | Oral pharmaceutical dosage forms |
| CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| BRPI0918904B8 (pt) | 2008-09-04 | 2021-05-25 | Amylin Pharmaceuticals Inc | formulação pré-misturada fabricada para injeção, seu uso e kit compreendendo a mesma |
| HRP20170929T1 (hr) | 2008-09-17 | 2017-09-22 | Chiasma Inc. | Farmaceutski pripravci i odgovarajući postupci za isporuku |
| US20100092566A1 (en) * | 2008-10-15 | 2010-04-15 | Alessi Thomas R | Highly concentrated drug particles, formulations, suspensions and uses thereof |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| WO2010146536A1 (en) | 2009-06-18 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Suspension of particles with drug |
| WO2011007327A2 (en) | 2009-07-16 | 2011-01-20 | Koninklijke Philips Electronics N.V. | Suspension for therapeutic use and device for delivering said suspension |
| DK2462246T3 (da) | 2009-09-28 | 2017-11-06 | Intarcia Therapeutics Inc | Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse |
| US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| MX347014B (es) * | 2010-11-24 | 2017-04-07 | Durect Corp | Composición para administración de fármaco biodegradable. |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| CN105764491A (zh) | 2013-12-09 | 2016-07-13 | 度瑞公司 | 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法 |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| AU2016215350B2 (en) | 2015-02-03 | 2021-11-25 | Amryt Endo, Inc. | Method of treating diseases |
| US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
| MA53353A (fr) | 2016-05-16 | 2021-06-09 | Intarcia Therapeutics Inc | Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| JP7258561B2 (ja) | 2016-07-06 | 2023-04-17 | オリエント ファーマ シーオー．，エルティーディー． | 薬物組成物、バリヤー層及び薬物層を有している経口投与形態 |
| KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
| KR20230145053A (ko) | 2021-01-12 | 2023-10-17 | 듀렉트 코퍼레이션 | 지속 방출 약물 전달 시스템 및 관련 방법 |
| CN117159480B (zh) * | 2023-11-01 | 2024-03-01 | 江西赛基生物技术有限公司 | 一种重组人IFN-γ蛋白冻干小球及其制备方法和应用 |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797492A (en) * | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
| US3987790A (en) * | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
| US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4305927A (en) * | 1979-02-05 | 1981-12-15 | Alza Corporation | Method for the management of intraocular pressure |
| US4865845A (en) * | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices |
| US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
| US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
| US5110596A (en) * | 1988-12-13 | 1992-05-05 | Alza Corporation | Delivery system comprising means for delivering agent to livestock |
| US5057318A (en) * | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
| US5059423A (en) * | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation |
| US5219572A (en) * | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
| US5112614A (en) * | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
| US5234693A (en) * | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
| US5234692A (en) * | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
| US5151093A (en) * | 1990-10-29 | 1992-09-29 | Alza Corporation | Osmotically driven syringe with programmable agent delivery |
| GB9027422D0 (en) * | 1990-12-18 | 1991-02-06 | Scras | Osmotically driven infusion device |
| US5137727A (en) * | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
| US5288214A (en) * | 1991-09-30 | 1994-02-22 | Toshio Fukuda | Micropump |
| DE4137649C2 (de) * | 1991-11-15 | 1997-11-20 | Gerhard Dingler | Bauelement |
| US5308348A (en) * | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect |
| US5368588A (en) * | 1993-02-26 | 1994-11-29 | Bettinger; David S. | Parenteral fluid medication reservoir pump |
| US5639477A (en) * | 1993-06-23 | 1997-06-17 | Alza Corporation | Ruminal drug delivery device |
| US5697975A (en) * | 1994-02-09 | 1997-12-16 | The University Of Iowa Research Foundation | Human cerebral cortex neural prosthetic for tinnitus |
| NL9401150A (nl) * | 1994-07-12 | 1996-02-01 | Nederland Ptt | Werkwijze voor het aan een ontvangzijde aanbieden van een van een zendzijde afkomstig eerste aantal videosignalen, alsmede systeem, alsmede zender, alsmede netwerk, en alsmede ontvanger. |
| EP0788351B1 (en) * | 1994-11-10 | 2003-02-05 | The University of Kentucky Research Foundation | Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body |
| US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| US6395292B2 (en) * | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6156331A (en) * | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6261584B1 (en) * | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| PL189289B1 (pl) * | 1996-02-02 | 2005-07-29 | Alza Corp | Sposób przygotowania implantowanego układu do dostarczania substancji aktywnej |
| US6132420A (en) * | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| US5976109A (en) * | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
| US5932547A (en) * | 1996-07-03 | 1999-08-03 | Alza Corporation | Non-aqueous polar aprotic peptide formulations |
| AU739469B2 (en) * | 1996-12-20 | 2001-10-11 | Alza Corporation | Gel composition and methods |
| ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
| MY125849A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| US6299869B1 (en) * | 1997-12-08 | 2001-10-09 | Genentech, Inc. | Human interferon-epsilon: a type I interferon |
| KR100576583B1 (ko) * | 1997-12-22 | 2006-05-04 | 알자 코포레이션 | 서방성 약물 송달 장치용 속도 조절막 |
| WO1999033446A1 (en) * | 1997-12-29 | 1999-07-08 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism |
| PT1300129E (pt) * | 1997-12-29 | 2005-07-29 | Alza Corp | Tubo para implante |
| KR100568917B1 (ko) * | 1997-12-30 | 2006-04-07 | 알자 코포레이션 | 멤브레인 플러그를 갖는 익제 전달장치 |
| US6248112B1 (en) * | 1998-09-30 | 2001-06-19 | C. R. Bard, Inc. | Implant delivery system |
| EP1652516A3 (en) * | 1998-11-02 | 2006-05-17 | ALZA Corporation | Osmotic controlled delivery of active agents |
| CA2356860C (en) * | 1998-12-31 | 2006-11-07 | Alza Corporation | Osmotic delivery system having space efficient piston |
| US7258869B1 (en) * | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| US20030059376A1 (en) * | 1999-06-04 | 2003-03-27 | Libbey Miles A. | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| US6436091B1 (en) * | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| EP1328256B1 (en) * | 1999-12-21 | 2005-10-19 | Alza Corporation | Valve for osmotic devices |
| US6283949B1 (en) * | 1999-12-27 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Refillable implantable drug delivery pump |
| US20030211974A1 (en) * | 2000-03-21 | 2003-11-13 | Brodbeck Kevin J. | Gel composition and methods |
| US6840831B2 (en) * | 2000-09-05 | 2005-01-11 | Robert Katz | Kickboard |
| AU2587002A (en) * | 2000-11-03 | 2002-05-15 | Biomedicines Inc | Method for short-term and long-term drug dosimetry |
| IL159048A0 (en) * | 2001-06-21 | 2004-05-12 | Genentech Inc | Sustained release formulation |
| US7163688B2 (en) * | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| AU2003221888B2 (en) * | 2002-04-11 | 2008-11-06 | Medimmune, Llc | Preservation of bioactive materials by spray drying |
| EP1536767B1 (en) * | 2002-06-17 | 2007-08-08 | Alza Corporation | Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| CN100453130C (zh) * | 2002-06-26 | 2009-01-21 | 精达制药公司 | 用于渗透性药物传递系统的最低顺应性和高容积效率的活塞 |
| IL166418A0 (en) * | 2002-07-31 | 2006-01-15 | Alza Corp | Injectable depot compositions and uses thereof |
| BR0315304A (pt) * | 2002-11-06 | 2005-08-16 | Alza Corp | Formulações com depósito para liberação controlada |
| US7014636B2 (en) * | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| RU2342118C2 (ru) * | 2002-12-19 | 2008-12-27 | Алза Корпорейшн | Стабильные неводные однофазные гели и композиции на их основе для доставки из имплантируемого устройства |
| US20050008661A1 (en) * | 2003-03-31 | 2005-01-13 | Fereira Pamela J. | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| CA2520766A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| EP1613389B8 (en) * | 2003-03-31 | 2008-05-07 | Intarcia Therapeutics, Inc. | Osmotic pump with means for dissipating internal pressure |
| BRPI0414941A (pt) * | 2003-09-30 | 2006-11-07 | Alza Corp | dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente |
| PL380763A1 (pl) * | 2003-10-31 | 2007-03-05 | Alza Corporation | Pompa osmotyczna z samoczynnie mocowanym korkiem membranowym szybkiego uruchamiania |
| KR20060121890A (ko) * | 2003-11-06 | 2006-11-29 | 알자 코포레이션 | 이식형 삼투 펌프와 함께 사용하기 위한 모듈식 흡수율감소기 |
| US20050118206A1 (en) * | 2003-11-14 | 2005-06-02 | Luk Andrew S. | Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| US20050175701A1 (en) * | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
| US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| US20060142234A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
| US20060141040A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
| WO2006083761A2 (en) * | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US20060216242A1 (en) * | 2005-02-03 | 2006-09-28 | Rohloff Catherine M | Suspending vehicles and pharmaceutical suspensions for drug dosage forms |
| EP1877077A2 (en) * | 2005-02-03 | 2008-01-16 | Intarcia Therapeutics, Inc. | An implantable interferon-containing device |
| US7959938B2 (en) * | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems |
| US20070027105A1 (en) * | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| MX2009001114A (es) * | 2006-08-09 | 2009-02-10 | Intarcia Therapeutics Inc | Sistemas de suministro osmotico y ensambles de piston. |
| CN104000779A (zh) * | 2007-04-23 | 2014-08-27 | 精达制药公司 | 促胰岛素释放肽的混悬制剂及其应用 |
| CA2726861C (en) * | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
-
2005
- 2005-05-19 US US11/132,830 patent/US20050266087A1/en not_active Abandoned
- 2005-05-23 KR KR1020067027172A patent/KR20070046791A/ko not_active Ceased
- 2005-05-23 DE DE602005008053T patent/DE602005008053D1/de not_active Expired - Lifetime
- 2005-05-23 ES ES05753131T patent/ES2309768T3/es not_active Expired - Lifetime
- 2005-05-23 PE PE2005000567A patent/PE20060456A1/es not_active Application Discontinuation
- 2005-05-23 AU AU2005247439A patent/AU2005247439B2/en not_active Ceased
- 2005-05-23 JP JP2007515217A patent/JP2008500345A/ja not_active Withdrawn
- 2005-05-23 WO PCT/US2005/017914 patent/WO2005115333A2/en not_active Ceased
- 2005-05-23 BR BRPI0511593-0A patent/BRPI0511593A/pt not_active IP Right Cessation
- 2005-05-23 CA CA002568714A patent/CA2568714A1/en not_active Abandoned
- 2005-05-23 EP EP05753131A patent/EP1755650B8/en not_active Expired - Lifetime
- 2005-05-23 AT AT05753131T patent/ATE400291T1/de not_active IP Right Cessation
- 2005-05-23 MX MXPA06013755A patent/MXPA06013755A/es active IP Right Grant
- 2005-05-23 NZ NZ551258A patent/NZ551258A/en unknown
- 2005-05-24 TW TW094116804A patent/TW200611712A/zh unknown
- 2005-05-24 AR ARP050102150A patent/AR049118A1/es not_active Application Discontinuation
-
2006
- 2006-11-14 IL IL179279A patent/IL179279A/en not_active IP Right Cessation
-
2008
- 2008-01-11 US US12/008,553 patent/US20080112994A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500345A5 (enExample) | ||
| TW200611712A (en) | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium | |
| US11707549B2 (en) | Adhesive containing microparticles | |
| Ueno et al. | Drug-incorporating calcium carbonate nanoparticles for a new delivery system | |
| HRP20230463T1 (hr) | Stabilna anti-ifnar1 formulacija | |
| JP2015527402A5 (enExample) | ||
| JP2006510655A5 (enExample) | ||
| NZ730821A (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
| JP2015509788A5 (enExample) | ||
| JP2013528227A (ja) | ナノ粒子フィルム送達システム | |
| IL164222A0 (en) | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | |
| Chopra et al. | Synthesis and optimization of streptomycin loaded chitosan-alginate nanoparticles | |
| JP2015500342A5 (enExample) | ||
| WO2015152693A3 (ko) | 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물 | |
| FI3197433T3 (fi) | Lipidien ja liposomien stabiileja koostumuksia | |
| JP2015525763A5 (enExample) | ||
| JP2017525671A5 (enExample) | ||
| Choi et al. | Polymer-coated spherical mesoporous silica for pH-controlled delivery of insulin | |
| JP2005530822A5 (enExample) | ||
| JP2025038069A (ja) | イブプロフェンを含む薬学的組成物の凝集、通気の最小化、及びコーティングの保存 | |
| JP2009544665A5 (enExample) | ||
| JP2020510705A5 (enExample) | ||
| AU2007325512A1 (en) | Particles for cell targeting | |
| WO2016084849A1 (ja) | ヤヌス微粒子及びその製造方法 | |
| Li et al. | Novel pMDI formulations for pulmonary delivery of proteins |